PharmaBoardroom

Pharma Country Managers: The COVID Generation

While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive, working around the clock to ensure…

France: ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal;…

The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…

Population Health: Access & AntiVax Challenges

Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to clean water. It is estimated by global…

Viatris: Cost-Cutting Needed at New Generics Behemoth

In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and Pfizer's Upjohn generics unit finally…

Stefan Hendriks – Global Head Cell & Gene, Novartis…

Stefan Hendriks, Global Head of Novartis Oncology’s Cell & Gene division outlines the company’s progression to becoming the global leader in…

Tim Philippi – Executive Director, Singaporean-German…

The SGC's Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance of healthcare and the life sciences…

Khalid Saleh – Managing Director, Mera Pharma

Mera Pharma’s Khalid Saleh introduces the Swiss-headquartered but MENA-focused company, how it plans to expand via CMOs, and its evolution from food…

JP Morgan 2021 Virtual Healthcare Conference: A Course Correction…

David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual format, noting potential changes in…

5 Top Trends in Chinese Healthcare & Biopharma in 2020

2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being discovered in China around the beginning…

Embryonic Gene Editing: How Far is Too Far to Find a Treatment…

Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing. With CRISPR technology again in the…

APAC: Prestige & HH&L IPO News; Cold Chain Vaccine…

The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L Acquisition; logistics challenges for…

What to Expect if Janet Woodcock Becomes Permanent FDA Head

Hours after President Biden was inaugurated on Tuesday 19th January 2021, Dr Janet Woodcock was named as acting commissioner for the Food and Drugs…

Tagged with A